On the recordNovember 16, 2015
I continue to feel as if there's a serious risk in not providing notice that a product is a biosimilar.
Source
congress.govEditor's note · Context
Senator Scott expresses concern over the lack of notice regarding biosimilar products.
Share
More from Tim Scott
Jul 16, 2026
The president's enthusiasm around Russell Fry probably is no surprise to anybody, but I have not seen and heard of an endorsement yet coming out of the White House.
Aug 9, 2026
In doing so, we are committed to avoiding another unnecessary shutdown, ensuring hardworking Americans continue receiving their paychecks, and protecting critical programs and services for families in South Carolina and across the country.
Other voices in this conversation
